103 related articles for article (PubMed ID: 19077900)
1. Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience.
Benden C; Speich R; Hofbauer GF; Irani S; Eich-Wanger C; Russi EW; Weder W; Boehler A
Transplantation; 2008 Dec; 86(11):1625-7. PubMed ID: 19077900
[TBL] [Abstract][Full Text] [Related]
2. Early extracorporeal photopheresis treatment is associated with better survival in patients with chronic or recurrent acute lung allograft dysfunction.
Gautschi F; Vogelmann T; Ortmanns G; Knörr F; Steinack C; Hage R; Nägeli M; Schuurmans MM
J Clin Apher; 2024 Jun; 39(3):e22128. PubMed ID: 38829041
[TBL] [Abstract][Full Text] [Related]
3. Extracorporeal photopheresis (ECP) in the treatment of chronic lung allograft dysfunction (CLAD): a prospective, multicentre, open-label, randomised controlled trial studying the addition of ECP to standard care in the treatment of bilateral lung transplant patients with CLAD (E-CLAD UK).
Fisher AJ; White M; Goudie N; Kershaw A; Phillipson J; Bardgett M; Lally J; Bevin-Nicholls A; Chadwick T; Bryant A; Russell S; Smith H; Frisby L; Errington R; Carby M; Thompson R; Santhanakrishnan K; Parmar J; Lordan JL; Vale L; Hancock H; Exley C; Gennery AR; Wason JM
BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38724453
[TBL] [Abstract][Full Text] [Related]
4. A European Multi-Center Analysis of Extracorporeal Photopheresis as Therapy for Chronic Lung Allograft Dysfunction.
Benazzo A; Bagnera C; Ius F; Del Fante C; Gottlieb J; Hoetzenecker K; Meloni F; Jaksch P; Greer M
Transpl Int; 2023; 36():11551. PubMed ID: 38282747
[TBL] [Abstract][Full Text] [Related]
5. The value of extracorporeal photopheresis as an immunosuppression-modifying approach in solid organ transplantation: a potential solution to an unmet medical need.
Augusto JF; Benden C; Diekmann F; Zuckermann A
Front Immunol; 2024; 15():1371554. PubMed ID: 38846942
[TBL] [Abstract][Full Text] [Related]
6. Risk of keratinocyte carcinomas following extracorporeal photopheresis among lung transplant recipients: A retrospective cohort study.
Chen DZ; Wang CX; Huecker JB; Russell AJ; Anadkat MJ
J Am Acad Dermatol; 2024 Feb; 90(2):388-390. PubMed ID: 37802186
[No Abstract] [Full Text] [Related]
7. The use of extracorporeal photopheresis in solid organ transplantation-current status and future directions.
Barten MJ; Fisher AJ; Hertig A
Am J Transplant; 2024 Mar; ():. PubMed ID: 38490642
[TBL] [Abstract][Full Text] [Related]
8. Effects of Ramadan Fasting on Extracorporeal Photopheresis Outcomes.
Castillo-Aleman YM; Martinez MA; Ventura-Carmenate Y; Villegas-Valverde CA; Bencomo-Hernandez AA; Rivero Jimenez RA; Al-Kaabi FM
Cureus; 2023 Oct; 15(10):e47612. PubMed ID: 37886650
[TBL] [Abstract][Full Text] [Related]
9. A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation.
Jaksch P; Scheed A; Keplinger M; Ernst MB; Dani T; Just U; Nahavandi H; Klepetko W; Knobler R
J Heart Lung Transplant; 2012 Sep; 31(9):950-7. PubMed ID: 22884382
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation.
Morrell MR; Despotis GJ; Lublin DM; Patterson GA; Trulock EP; Hachem RR
J Heart Lung Transplant; 2010 Apr; 29(4):424-31. PubMed ID: 19853479
[TBL] [Abstract][Full Text] [Related]
11. Guidelines on the use of extracorporeal photopheresis.
Knobler R; Berlin G; Calzavara-Pinton P; Greinix H; Jaksch P; Laroche L; Ludvigsson J; Quaglino P; Reinisch W; Scarisbrick J; Schwarz T; Wolf P; Arenberger P; Assaf C; Bagot M; Barr M; Bohbot A; Bruckner-Tuderman L; Dreno B; Enk A; French L; Gniadecki R; Gollnick H; Hertl M; Jantschitsch C; Jung A; Just U; Klemke CD; Lippert U; Luger T; Papadavid E; Pehamberger H; Ranki A; Stadler R; Sterry W; Wolf IH; Worm M; Zic J; Zouboulis CC; Hillen U
J Eur Acad Dermatol Venereol; 2014 Jan; 28 Suppl 1(Suppl 1):1-37. PubMed ID: 24354653
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of extracorporeal photopheresis in clearance of antibodies to donor-specific and lung-specific antigens in lung transplant recipients.
Baskaran G; Tiriveedhi V; Ramachandran S; Aloush A; Grossman B; Hachem R; Mohanakumar T
J Heart Lung Transplant; 2014 Sep; 33(9):950-6. PubMed ID: 24906794
[TBL] [Abstract][Full Text] [Related]
13. Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients.
Greer M; Dierich M; De Wall C; Suhling H; Rademacher J; Welte T; Haverich A; Warnecke G; Ivanyi P; Buchholz S; Gottlieb J; Fuehner T
Am J Transplant; 2013 Apr; 13(4):911-918. PubMed ID: 23406373
[TBL] [Abstract][Full Text] [Related]
14. Lung transplant recipients on long-term extracorporeal photopheresis.
Isenring B; Robinson C; Buergi U; Schuurmans MM; Kohler M; Huber LC; Benden C
Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28653398
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte Depleting and Modulating Therapies for Chronic Lung Allograft Dysfunction.
Bos S; Pradère P; Beeckmans H; Zajacova A; Vanaudenaerde BM; Fisher AJ; Vos R
Pharmacol Rev; 2023 Nov; 75(6):1200-1217. PubMed ID: 37295951
[TBL] [Abstract][Full Text] [Related]
16. Effective Extracorporeal Photopheresis of Patients with Transplantation Induced Acute Intestinal GvHD and Bronchiolitis Obliterans Syndrome.
Reschke R; Zimmerlich S; Döhring C; Behre G; Ziemer M
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009436
[No Abstract] [Full Text] [Related]
17. Drugging the efferocytosis process: concepts and opportunities.
Mehrotra P; Ravichandran KS
Nat Rev Drug Discov; 2022 Aug; 21(8):601-620. PubMed ID: 35650427
[TBL] [Abstract][Full Text] [Related]
18. Pre-transplant infusion of donor leukocytes treated with extracorporeal photochemotherapy induces immune hypo-responsiveness and long-term allograft survival in murine models.
Schneiderman J; Qiu L; Yeap XY; Kang X; Zheng F; Ye J; Xie Y; Wang JJ; Sambandam Y; Mathew J; Li L; Leventhal J; Edelson RL; Zhang ZJ
Sci Rep; 2022 May; 12(1):7298. PubMed ID: 35508582
[TBL] [Abstract][Full Text] [Related]
19. Management of chronic rejection after lung transplantation.
Bedair B; Hachem RR
J Thorac Dis; 2021 Nov; 13(11):6645-6653. PubMed ID: 34992842
[TBL] [Abstract][Full Text] [Related]
20. Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction.
; Hage CA; Klesney-Tait J; Wille K; Arcasoy S; Yung G; Hertz M; Chan KM; Morrell M; Goldberg H; Vedantham S; Derfler MC; Commean P; Berman K; Spitznagel E; Atkinson J; Despotis G
Transfus Med; 2021 Aug; 31(4):292-302. PubMed ID: 33955079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
